how long has ipamorelin been around What Is Ipamorelin? Complete Research

Mogami S, Suzuki H, Fukuhara S, Matsuzaki J, Kangawa K, Hibi T

IGF-1 axis: in animal model research, GH-axis stimulation by CJC-1295 + ipamorelin has been associated with downstream increases in IGF-1, the principal mediator of many of GH's tissue effects

This chemical modification binds the peptide to albumin in the blood, significantly extending its half-life and allowing stable GH pulses for days , rather than minutes

This binding triggers a cascade of cellular responses that stimulate the release of growth hormone (GH) from the pituitary gland, which subsequently increases circulating insulin-like growth factor-1 (IGF-1) levels

It has been the subject of scientific and pharmaceutical research

Typical dosing protocol: Duration runs 4-6 weeks before evaluating progress